Merit Medical Systems (MMSI) Stock Forecast, Price & News

Merit Medical Systems (NASDAQ:MMSI) Frequently Asked Questions

Is Merit Medical Systems a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Merit Medical Systems stock.
View analyst ratings for Merit Medical Systems or view top-rated stocks.

Are investors shorting Merit Medical Systems?

Merit Medical Systems saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 1,640,000 shares, an increase of 43.9% from the April 30th total of 1,140,000 shares. Based on an average trading volume of 431,800 shares, the days-to-cover ratio is currently 3.8 days. Currently, 3.0% of the company's shares are sold short.
View Merit Medical Systems' Short Interest.

When is Merit Medical Systems' next earnings date?

Merit Medical Systems is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Merit Medical Systems.

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) announced its quarterly earnings data on Wednesday, April, 27th. The medical instruments supplier reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.06. The medical instruments supplier earned $275.42 million during the quarter, compared to analysts' expectations of $263.46 million. Merit Medical Systems had a net margin of 4.36% and a trailing twelve-month return on equity of 13.33%. During the same quarter in the prior year, the business posted $0.52 EPS.
View Merit Medical Systems' earnings history.

What guidance has Merit Medical Systems issued on next quarter's earnings?

Merit Medical Systems issued an update on its FY22 earnings guidance on Wednesday, April, 27th. The company provided EPS guidance of $2.41-2.56 for the period, compared to the consensus EPS estimate of $2.48. The company issued revenue guidance of $1.117-1.140 billion, compared to the consensus revenue estimate of $1.13 billion.

What price target have analysts set for MMSI?

5 equities research analysts have issued 12 month price objectives for Merit Medical Systems' shares. Their forecasts range from $72.00 to $78.00. On average, they anticipate Merit Medical Systems' stock price to reach $74.40 in the next twelve months. This suggests a possible upside of 19.0% from the stock's current price.
View analysts' price targets for Merit Medical Systems or view top-rated stocks among Wall Street analysts.

Who are Merit Medical Systems' key executives?

Merit Medical Systems' management team includes the following people:

• Mr. Fred P. Lampropoulos, Founder, Chairman, CEO & Pres (Age 72, Pay $3.39M)
• Mr. Raul Parra Jr., CPA, CFO & Treasurer (Age 43, Pay $1.01M)
• Mr. Brian G. Lloyd, Chief Legal Officer & Corp. Sec. (Age 61, Pay $965.29k) (LinkedIn Profile)
• Mr. Joseph C. Wright, Pres of International Division (Age 52, Pay $948.74k) (LinkedIn Profile)
• Mr. Neil Peterson, Chief Operating Officer
• Mr. Jason Treft, Chief Technology Officer
• Mr. Joseph Pierce, Chief Information Officer
• Mr. Michel J. Voigt, Chief HR Officer (Age 49)
• Mr. John Knorpp, Chief Regulatory Affairs Officer
• Dr. Nicole Priest, Chief Wellness Officer

What is Fred P. Lampropoulos' approval rating as Merit Medical Systems' CEO?

158 employees have rated Merit Medical Systems CEO Fred P. Lampropoulos on Glassdoor.com. Fred P. Lampropoulos has an approval rating of 73% among Merit Medical Systems' employees.

Who are some of Merit Medical Systems' key competitors?

Some companies that are related to Merit Medical Systems include West Pharmaceutical Services (WST), Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), ICU Medical (ICUI), Quidel (QDEL), Haemonetics (HAE), STAAR Surgical (STAA), Neogen (NEOG), Meridian Bioscience (VIVO), Atrion (ATRI), Cerus (CERS), Antares Pharma (ATRS), Anika Therapeutics (ANIK) and OraSure Technologies (OSUR).
View all of MMSI's competitors.

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

What is Merit Medical Systems' stock symbol?

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.83%), Vanguard Group Inc. (10.24%), William Blair Investment Management LLC (5.92%), Conestoga Capital Advisors LLC (4.48%), State Street Corp (3.32%) and Dimensional Fund Advisors LP (2.83%). Company insiders that own Merit Medical Systems stock include A Scott Anderson, Brian G Lloyd, David Floyd, David Ming-Teh Liu, Fred P Lampropoulos, Jill Anderson, Joseph Wright, Lynne Ward, Raul Jr Parra and Ronald Frost.
View institutional ownership trends for Merit Medical Systems.

Which institutional investors are selling Merit Medical Systems stock?

MMSI stock was sold by a variety of institutional investors in the last quarter, including Starboard Value LP, Goldman Sachs Group Inc., Invesco Ltd., Polar Capital Holdings Plc, Emerald Mutual Fund Advisers Trust, Rothschild & Co. Asset Management US Inc., State Street Corp, and BNP Paribas Arbitrage SA. Company insiders that have sold Merit Medical Systems company stock in the last year include Brian G Lloyd, Jill Anderson, Lynne Ward, and Ronald Frost.
View insider buying and selling activity for Merit Medical Systems or view top insider-selling stocks.

Which institutional investors are buying Merit Medical Systems stock?

MMSI stock was purchased by a variety of institutional investors in the last quarter, including Fuller & Thaler Asset Management Inc., Vanguard Group Inc., BlackRock Inc., Loomis Sayles & Co. L P, Allianz Asset Management GmbH, Assenagon Asset Management S.A., Emerald Advisers LLC, and Healthcare of Ontario Pension Plan Trust Fund.
View insider buying and selling activity for Merit Medical Systems or or view top insider-buying stocks.

How do I buy shares of Merit Medical Systems?

Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Merit Medical Systems' stock price today?

One share of MMSI stock can currently be purchased for approximately $62.51.

How much money does Merit Medical Systems make?

Merit Medical Systems has a market capitalization of $3.54 billion and generates $1.07 billion in revenue each year. The medical instruments supplier earns $48.45 million in net income (profit) each year or $0.84 on an earnings per share basis.

How many employees does Merit Medical Systems have?

Merit Medical Systems employs 6,446 workers across the globe.

Does Merit Medical Systems have any subsidiaries?

The following companies are subsidiares of Merit Medical Systems: Alveolus Inc., Argon Medical Devices Netherlands BV, BSMD Ventures Inc., BioSphere Medical Inc., BioSphere Medical Japan Inc., BioSphere Medical SA, Brightwater Medical Inc., Brightwater Medical Inc., Cianna Medical Inc., DFINE Inc., Dfine Europe GmbH, Fibrovein Holdings Limited, ITL Healthcare Pty Ltd., IntelliMedical Technologies Pty Ltd., LLC Merit Technologies, Merit Holdings Inc., Merit Maquiladora México S. DE R.L. DE C.V., Merit Medical (NRI) Ireland Limited, Merit Medical Africa (Pty) LTD, Merit Medical Asia Company Limited, Merit Medical Australia Pty Ltd., Merit Medical Austria GmbH, Merit Medical Beijing Co. Ltd., Merit Medical Belgium Sprl, Merit Medical Canada Ltd., Merit Medical Coatings B.V., Merit Medical Comercialização Distribuição Importação e Exportação de Produtos Hospitalares LTDA., Merit Medical Denmark A/S, Merit Medical Egypt LLC, Merit Medical Finland Ltd., Merit Medical France SAS, Merit Medical GmbH, Merit Medical Ireland Ltd., Merit Medical Italy S.R.L., Merit Medical Japan KK, Merit Medical Korea Co. Ltd., Merit Medical ME FZ-LLC, Merit Medical Malaysia Sdn. Bhd, Merit Medical Nederland B.V., Merit Medical New Zealand Limited, Merit Medical Norway AS, Merit Medical Portugal S.A., Merit Medical Singapore Holdings Pte. Ltd, Merit Medical Singapore Pte. Ltd., Merit Medical South Africa (Pty) LTD, Merit Medical Spain S.L.Unipersonal, Merit Medical Switzerland AG, Merit Medical Systems AB, Merit Medical Systems India Private Limited, Merit Medical System’s NRI Limited, Merit Medical Turkey Tıbbi Ürünler Ticaret Anonim Şirketi, Merit Medical UK Limited, Merit Mexico Sales S. de R.L. de C.V., Merit Sensor Systems Inc., STD Pharmaceutical (Ireland) Limited, STD Pharmaceutical Products Limited, Thomas Medical Products Inc., Vascular Access Technologies Inc., and Vascular Insights LLC.

When was Merit Medical Systems founded?

Merit Medical Systems was founded in 1987.

What is Merit Medical Systems' official website?

The official website for Merit Medical Systems is www.merit.com.

How can I contact Merit Medical Systems?

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at (801) 253-1600, via email at [email protected], or via fax at 801-253-1652.